Effect of resveratrol on growth of 4T1 breast cancer cells in vitro and in vivo.

Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol (2007) 2.65

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One (2011) 1.74

Resveratrol, sirtuins, and the promise of a DR mimetic. Mech Ageing Dev (2010) 1.39

Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer (2014) 1.24

Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des (2013) 1.22

Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice. World J Gastroenterol (2005) 1.18

Resveratrol in prevention and treatment of common clinical conditions of aging. Clin Interv Aging (2008) 1.17

Resveratrol and estradiol exert disparate effects on cell migration, cell surface actin structures, and focal adhesion assembly in MDA-MB-231 human breast cancer cells. Neoplasia (2005) 1.06

EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem Biophys Res Commun (2008) 0.99

Resveratrol induces apoptosis in human esophageal carcinoma cells. World J Gastroenterol (2003) 0.96

Inhibition of breast cancer metastasis by resveratrol-mediated inactivation of tumor-evoked regulatory B cells. J Immunol (2013) 0.90

Resveratrol induces long-lasting IL-8 expression and peculiar EGFR activation/distribution in human keratinocytes: mechanisms and implications for skin administration. PLoS One (2013) 0.89

Effect of resveratrol on the metastasis of 4T1 mouse breast cancer cells in vitro and in vivo. Nutr Res Pract (2012) 0.87

Natural compounds as anticancer agents: Experimental evidence. World J Exp Med (2012) 0.82

Synergistic effects of glycated chitosan with high-intensity focused ultrasound on suppression of metastases in a syngeneic breast tumor model. Cell Death Dis (2014) 0.81

An analogue of resveratrol HS-1793 exhibits anticancer activity against MCF-7 cells via inhibition of mitochondrial biogenesis gene expression. Mol Cells (2012) 0.80

Resveratrol analogue HS-1793 induces the modulation of tumor-derived T cells. Exp Ther Med (2012) 0.79

The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models. Cell Death Dis (2014) 0.79

Diverse animal models to examine potential role(s) and mechanism of endocrine disrupting chemicals on the tumor progression and prevention: Do they have tumorigenic or anti-tumorigenic property? Lab Anim Res (2011) 0.78

Curcumin Affects Phase II Disposition of Resveratrol Through Inhibiting Efflux Transporters MRP2 and BCRP. Pharm Res (2015) 0.76

4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells. Toxicol Appl Pharmacol (2016) 0.76

Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages. J Biol Chem (2002) 2.06

Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages. J Biol Chem (2003) 1.39

Role of alpha(v)beta(3)-integrin in TNF-alpha-induced endothelial cell migration. Am J Physiol Cell Physiol (2002) 1.09

Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett (2007) 1.07

Induction of cytokines by heat shock proteins and endotoxin in murine macrophages. Biochem Biophys Res Commun (2004) 1.01

The heat sensitivity of cytokine-inducing effect of lipopolysaccharide. J Leukoc Biol (2006) 0.92

Health care operations activities that may constitute research: the Department of Veterans Affairs's perspective. IRB (2014) 0.87

Fertility cycle influence on surgical breast cancer cure. Breast Cancer Res Treat (2002) 0.86

Induction of cytokines by heat shock proteins and concanavalin A in murine splenocytes. Cytokine (2005) 0.79

Lapse in Institutional Review Board Continuing Review Approval. IRB (2015) 0.75

Human research protection programs at the Department of Veterans Affairs: quality indicators and program size. IRB (2014) 0.75